US4364401012
© BusinessWire
16.12.2025
HOLX
LISTED
NASDAQ
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
News Preview
Hologic, Inc. (Nasdaq: HOLX), a leading medical technology company dedicated to improving women’s health, today announced new data that highlights how the company’s advanced AI-powered mammography solution can aid in detecting more breast cancers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news...
Themefolio
Profiler
Peergroup
© BusinessWire
02.12.2025
HOLX
LISTED
NASDAQ
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration
News Preview
Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced that 11 studies featuring the Breast Cancer Index® (BCI™) Test will be presented at the 2025 San Antonio Breast Cancer Symposium® (SABCS). Findings from these studies support the company’s ongoing commitment to help inform personalized treatment recommendations...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2025
HOLX
LISTED
NASDAQ
New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA
News Preview
New data on Hologic’s (Nasdaq: HOLX) breast cancer detection technologies will be presented at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Illinois.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251125405988/en/Hologic’s 3D...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
12.11.2025
HOLX
LISTED
NASDAQ
Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that its Genius™ Digital Diagnostics System achieved expanded CE marking in the European Union and is now approved to image and review both cell and tissue specimens. Previously, the system was CE marked specifically for cell analysis, notably used in cervical cancer screening, among other applications....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
03.11.2025
HOLX
LISTED
NASDAQ
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 27, 2025. The Company reported revenue of $1,049.5 million, GAAP diluted EPS of $0.83, and non-GAAP diluted EPS of $1.13.
Highlights
On October 21, 2025, the Company announced it had entered into a definitive agreement to...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
HOLX
LISTED
NASDAQ
Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hologic, Inc. (NasdaqGS: HOLX) to funds managed by Blackstone and TPG. Under the terms of the proposed transaction, shareholders of Hologic will receive $76.00 per share in cash plus a non-tr...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
HOLX
LISTED
NASDAQ
HOLX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Hologic, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Hologic, Inc. (NASDAQ: HOLX) to funds managed by Blackstone and TPG is fair to Hologic shareholders. Under the terms of the proposed transaction, Hologic shareholders will receive $76.00 per share in cash plus a non-tradable contingent value right to receive up to...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
HOLX
LISTED
NASDAQ
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
News Preview
Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3 billion.1
This press release features multimedia. View the full release here: https://www....
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2025 on Monday, November 3, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by di...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
HOLX
LISTED
NASDAQ
Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fusion® Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The company also announced that the assays obtained CE marking in the European Union in accordance with In Vitro Diagnostic Regulation (IVD...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
HOLX
LISTED
NASDAQ
Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm
News Preview
HAUPPAUGE, N.Y., Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States. As Hologic transitions away from co...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
HOLX
LISTED
NASDAQ
New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI
News Preview
Data from two groundbreaking studies evaluating the performance of Hologic’s (Nasdaq: HOLX) artificial intelligence (AI)-powered mammography technology will be presented today at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting in Aberdeen, Scotland.
This press release features multimedia. View the full release here: http...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
03.09.2025
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 23rd Annual Morgan Stanley Global Healthcare Conference in New York at 10:45 a.m. Eastern Time on Tuesday, September 9th.
The fireside chat presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://...
Themefolio
Profiler
Peergroup
© BusinessWire
30.07.2025
HOLX
LISTED
NASDAQ
Hologic Announces Financial Results for Third Quarter of Fiscal 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal third quarter ended June 28, 2025.
“We are pleased to have delivered revenue and non-GAAP earnings growth in the third quarter that exceeded our guidance ranges,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer. “A...
Themefolio
Profiler
Peergroup
© BusinessWire
02.07.2025
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dia...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
HOLX
LISTED
NASDAQ
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients
News Preview
Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating the significant clinical impact of the Breast Cancer Index® (BCI®) test, which will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on June 2, 2025.
“These data highlight the critical role the Breast...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentations at Upcoming Investor Conferences
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences:
The 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20 at 9:30 a.m. Eastern Time (ET) in New York.
William Blair’s 45th Annual Growth Stock Conference in Chicago on Wednesday, June 4 at 4...
Themefolio
Profiler
Peergroup
© BusinessWire
01.05.2025
HOLX
LISTED
NASDAQ
Hologic Announces Financial Results for Second Quarter of Fiscal 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal second quarter ended March 29, 2025.
“We delivered on our financial commitments in the second quarter,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer. “Both revenue and non-GAAP EPS finished at the high ends of ou...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
HOLX
LISTED
NASDAQ
Groundbreaking New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at SBI
News Preview
Hologic, Inc. (Nasdaq: HOLX) will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado this week, including the presentation of pivotal new research conducted by a top-tier healthcare facility focused on the company’s AI-driven mammography technology.
This press release features multimedia. V...
Themefolio
Profiler
Peergroup
© BusinessWire
22.04.2025
HOLX
LISTED
NASDAQ
Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report
News Preview
Hologic, Inc. (Nasdaq: HOLX), a company that develops industry-leading technologies that detect, diagnose and treat life-changing health conditions that affect women, today released its annual sustainability report with an emphasis on expanded environmental commitments and efforts to advance access and equity in women’s health.
This press release...
Themefolio
Profiler
Peergroup
© BusinessWire
04.04.2025
HOLX
LISTED
NASDAQ
Wayde McMillan Elected to Hologic Board of Directors
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that Wayde McMillan has been elected to the Company’s Board of Directors, effective April 4, 2025. Mr. McMillan was also appointed to the Audit and Finance Committee effective April 4, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202504...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2025 on Thursday, May 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialin...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Tuesday, March 4 at 11 a.m. Eastern Time (ET).
The presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investor...
Themefolio
Profiler
Peergroup
© BusinessWire
20.02.2025
HOLX
LISTED
NASDAQ
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software
News Preview
Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm® Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate lesion targeting to help streamline workflow and accelerate biopsy procedures,1-2 is now CE-marked. The technology received clearance from the U.S. Food and Drug...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
HOLX
LISTED
NASDAQ
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted Emergency Use Authorization (EUA) status in May 2020.
“Our COVID test was instrumental in addressing critical testing needs during the pandemic and offered h...
Themefolio
Profiler
Peergroup
© BusinessWire
05.02.2025
HOLX
LISTED
NASDAQ
Hologic Announces Financial Results for First Quarter of Fiscal 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 28, 2024.
“Our financial results for the first quarter of 2025 were consistent with our guidance overall,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer. “Total revenue finished in li...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2025
HOLX
LISTED
NASDAQ
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
News Preview
Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index, one of the largest collections of data on women’s health and well-being.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121461870/en/
Hologic, Inc. (Nasdaq: HOLX), a leading wo...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2025
HOLX
LISTED
NASDAQ
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 28, 2024.
The Company expects to report total revenues of approximately $1,021.8 million, an increase of 0.9% compared to the prior year period, or 1.0% in constant currency.
“Our fiscal Q1 revenue finished in line with our guid...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2025
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 1:30 p.m. Pacific Time.
The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hol...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2025
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2025 on Wednesday, February 5, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2025
HOLX
LISTED
NASDAQ
Hologic Completes Acquisition of Gynesonics, Inc.
News Preview
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health, for approximately $350 million.
“We are excited to complete the acquisition o...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
HOLX
LISTED
NASDAQ
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
News Preview
Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests used to identify specific diseases or conditions — that would aid in the detection of H5N1 bird flu.
This...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2024
HOLX
LISTED
NASDAQ
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
News Preview
Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement regarding the United States Preventive Services Task Force draft guidelines for cervical cancer screening:
“Today’s recommendatio...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2024
HOLX
LISTED
NASDAQ
Martin Madaus Elected to Hologic Board of Directors
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024.
This press release features multimedia. View the full releas...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2024
HOLX
LISTED
NASDAQ
New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence
News Preview
Four new studies regarding the Breast Cancer Index (BCI) test will be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS). Among these studies, initial data will be premiered investigating the potential role of the BCI test to identify postmenopausal women with hormone-receptor positive (HR+), early-stage, node-negative disease who a...
Themefolio
Profiler
Peergroup
© BusinessWire
02.12.2024
HOLX
LISTED
NASDAQ
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
News Preview
Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI® Detection 2.0 software across diverse patient populations at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
This press release features multimedia. View the full release here: https:/...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
HOLX
LISTED
NASDAQ
Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024
News Preview
Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago on December 1-5. On the show floor and during multiple workshops, Hologic will showcase AI-powered breast imaging advancements designed...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2024
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentations at Upcoming Investor Conferences
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences:
2024 Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21st, at 10 a.m. Central Time (CT).
7th Annual Evercore ISI HealthCONx Conference in Coral Gables, FL on Tuesday, December 3rd, at 2:10 p....
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2024
HOLX
LISTED
NASDAQ
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 28, 2024.
"We delivered strong fiscal 2024 results, reinforcing our track record of durable performance with another solid quarter of growth," said Steve MacMillan, Hologic’s chairman, president, and chief executive officer....
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2024
HOLX
LISTED
NASDAQ
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
News Preview
Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 million, subject to working capital and...
Themefolio
Profiler
Peergroup
© BusinessWire
04.10.2024
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2024 on Monday, November 4, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dia...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2024
HOLX
LISTED
NASDAQ
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
News Preview
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, will kick off Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 18th year. As part of this annual tradition, Hologic is launching a comprehensive patient education campaign to bust common myths about breast cancer, mammograms and breast density.
This press rele...
Themefolio
Profiler
Peergroup
© BusinessWire
29.08.2024
HOLX
LISTED
NASDAQ
Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5th, at 12:20 p.m. Eastern Time.
The fire-side chat presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
